UBS upgraded Roche (RHHBY) to Buy from Neutral with a price target of CHF 338, up from CHF 300. The company offers sustainable growth with ...

Morgan Stanley initiated coverage of Roche (RHHBY) with an Equal Weight rating and CHF 305 price target The firm sees the end of Roche’s ...

1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Por conta do sucesso da primeira temporada, a Cartoon logo pediu para que os criadores bolassem ideias para futuros 39 episódios, mas tal tarefa não era tão fácil e também precisou de muitas ...

Memories came wrapped in a Japanese soldier's cloth. Your generous donation will be used to ensure the memory of our Defence Forces and what they have done for us, and what they continue to do for our ...

Jornalista e pós-graduada em Teoria da Comunicação. Também é radialista, com passagens por várias emissoras de rádio em São Paulo. Está na Folha desde 2018.